News + Filings Transactions
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
|
|
Leamon Christopher P
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 01/09/2023 |
4
| Leamon Christopher P (Chief Scientific Officer) has filed a Form 4 on Fusion Pharmaceuticals Inc.|
Txns:
| Granted 250,000 options to buy
@ $3.75, valued at
$937.5k
|
|
| 11/02/2021 |
4
| Leamon Christopher P (Chief Scientific Officer) has filed a Form 4 on Fusion Pharmaceuticals Inc.|
Txns:
| Granted 218,000 options to buy
@ $7.09, valued at
$1.5M
|
|
| 11/02/2021 |
3
| Leamon Christopher P (Chief Scientific Officer) has filed a Form 3 on Fusion Pharmaceuticals Inc. |
| 12/21/2018 |
4
| Leamon Christopher P (Vice President of Research) has filed a Form 4 on ENDOCYTE INC|
Txns:
| Disposed/sold 164,256 shares
@ $24, valued at
$3.9M
Disposed/sold 4,375 shares
@ $24, valued at
$105k
Disposed/sold 13,125 shares
@ $24, valued at
$315k
Disposed/sold 20,000 shares
@ $24, valued at
$480k
Disposed/sold 22,500 shares
@ $24, valued at
$540k
Disposed/sold 27,500 options to buy
@ $9.05, valued at
$248.9k
Disposed/sold 59,996 options to buy
@ $3.55, valued at
$213k
Disposed/sold 70,000 options to buy
@ $9.86, valued at
$690.2k
Disposed/sold 45,000 options to buy
@ $11.11, valued at
$500k
Disposed/sold 52,498 options to buy
@ $5.1, valued at
$267.7k
Disposed/sold 52,498 options to buy
@ $3.18, valued at
$166.9k
|
|
| 12/19/2018 |
4
| Leamon Christopher P (Vice President of Research) has filed a Form 4 on ENDOCYTE INC|
Txns:
| Exercised 20,000 options to buy
@ $2.54, valued at
$50.8k
Exercised 26,177 options to buy
@ $3.82, valued at
$100k
Exercised 13,089 options to buy
@ $7.49, valued at
$98k
Exercised 22,500 options to buy
@ $9.05, valued at
$203.6k
Exercised 20,004 options to buy
@ $3.55, valued at
$71k
Exercised 2 options to buy
@ $5.1, valued at
$10.2
Exercised 2 options to buy
@ $3.18, valued at
$6.4 |
|
| 10/16/2018 |
4/A
| Form 4/A - Statement of changes in beneficial ownership of securities: [Amend] |
| 10/09/2018 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 08/29/2018 |
4
| Leamon Christopher P (Vice President of Research) has filed a Form 4 on ENDOCYTE INC|
Txns:
| Sold 12,670 shares
@ $20.0002, valued at
$253.4k
Sold 4,696 shares
@ $20, valued at
$93.9k
Exercised 12,670 options to buy
@ $2.54, valued at
$32.2k
Exercised 4,696 options to buy
@ $2.54, valued at
$11.9k
|
|
| 06/13/2018 |
4
| Leamon Christopher P (Vice President of Research) has filed a Form 4 on ENDOCYTE INC|
Txns:
| Sold 13,089 shares
@ $15.0552, valued at
$197.1k
|
|
| 03/12/2018 |
4
| Leamon Christopher P (Vice President of Research) has filed a Form 4 on ENDOCYTE INC|
Txns:
| Sold 5,036 shares
@ $9.07, valued at
$45.7k
|
|
| 02/08/2018 |
4
| Leamon Christopher P (Vice President of Research) has filed a Form 4 on ENDOCYTE INC|
Txns:
| Paid exercise price by delivering 638 shares
@ $3, valued at
$1.9k
Granted 22,500 shares
@ $0
Granted 45,000 options to buy
@ $3.01, valued at
$135.5k
|
|
| 02/06/2018 |
4
| Leamon Christopher P (Vice President of Research) has filed a Form 4 on ENDOCYTE INC|
Txns:
| Paid exercise price by delivering 1,487 shares
@ $3.12, valued at
$4.6k
Paid exercise price by delivering 1,736 shares
@ $3.12, valued at
$5.4k
|
|
| 12/04/2017 |
4
| Leamon Christopher P (Vice President of Research) has filed a Form 4 on ENDOCYTE INC|
Txns:
| Sold 18,194 shares
@ $5.0318, valued at
$91.5k
Sold 5,037 shares
@ $5.0495, valued at
$25.4k
Exercised 26,178 options to buy
@ $3.06, valued at
$80.1k
|
|
| 10/06/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/07/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 02/03/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 01/04/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 02/18/2016 |
4
| Leamon Christopher P (Vice President of Research) has filed a Form 4 on ENDOCYTE INC|
Txns:
| Exercised 13,089 options to buy
@ $1.91, valued at
$25k
|
|
| 02/08/2016 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 08/17/2012 |
4
| Leamon Christopher P (Vice President of Research) has filed a Form 4 on ENDOCYTE INC|
Txns:
| Sold 10,000 shares
@ $9.6535, valued at
$96.5k
|
|
| 03/02/2012 |
4
| Leamon Christopher P (Vice President of Research) has filed a Form 4 on ENDOCYTE INC|
Txns:
| Granted 80,000 options to buy
@ $3.55, valued at
$284k
|
|
| 12/21/2011 |
4
| Leamon Christopher P (Vice President of Research) has filed a Form 4 on ENDOCYTE INC|
Txns:
| Bought 5,000 shares
@ $3.14, valued at
$15.7k
|
|
| 04/18/2011 |
4
| Leamon Christopher P (Vice President of Research) has filed a Form 4 on ENDOCYTE INC|
Txns:
| Granted 50,000 options to buy
@ $9.05, valued at
$452.5k
|
|
| 03/28/2011 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 03/14/2011 |
4
| Leamon Christopher P (Vice President of Research) has filed a Form 4 on ENDOCYTE INC|
Txns:
| Granted 13,089 options to buy
@ $7.49, valued at
$98k
|
|
| 02/04/2011 |
3
| Leamon Christopher P (Vice President of Research) has filed a Form 3 on ENDOCYTE INC |
|
|